Abstract
TPS4575Background: Current treatment options for metastatic UC remain limited, and tolerability is a concern in many pts. Alterations in the fibroblast growth factor receptor (FGFR) pathway are imp...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
